Evidence map›Paper›PMID 35509838›Full record

ReviewOxidative medicine and cellular longevity2022

Pharmacological Properties of Bergapten: Mechanistic and Therapeutic Aspects.

Maria Magdalena Quetglas-Llabrés, Cristina Quispe, Jesús Herrera-Bravo, Marcelo D Catarino, Olívia R Pereira, Susana M Cardoso, Kamal Dua, Dinesh Kumar Chellappan, Kavita Pabreja, Saurabh Satija and 12 more

RetractedOpen access · hybridAbstract readReviewRetracted Publication
In one paragraph

Review in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Bioassay-Guided Fractionation ofPlants (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 17 institutions in 11 countries.

Maria Magdalena Quetglas-LlabrésResearch Group in Community Nutrition and Oxidative Stress, University of the Balearic Islands and Health Research Institute of Balearic Islands (IdISBa), 07122 Palma de Mallorca, Spain.
Cristina QuispeFacultad de Ciencias de la Salud, Universidad Arturo Prat, Avda. Arturo Prat 2120, Iquique 1110939, Chile.ORCID https://orcid.org/0000-0002-2090-3288
Jesús Herrera-BravoDepartamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomas, Chile.ORCID https://orcid.org/0000-0003-0739-7920
Marcelo D CatarinoLAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.
Olívia R PereiraCentro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.
Susana M CardosoLAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.
Kamal DuaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo NSW 2007, Australia.
Dinesh Kumar ChellappanDepartment of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur 57000, Malaysia.ORCID https://orcid.org/0000-0001-5567-6663
Kavita PabrejaSchool of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Delhi G.T. Road (NH-1), Phagwara, 144411 Punjab, India.
Saurabh SatijaSchool of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Delhi G.T. Road (NH-1), Phagwara, 144411 Punjab, India.
Meenu MehtaSchool of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Delhi G.T. Road (NH-1), Phagwara, 144411 Punjab, India.
Antoni SuredaResearch Group in Community Nutrition and Oxidative Stress, University of the Balearic Islands and Health Research Institute of Balearic Islands (IdISBa), 07122 Palma de Mallorca, Spain.ORCID https://orcid.org/0000-0001-8656-6838
Miquel MartorellDepartment of Nutrition and Dietetics, Faculty of Pharmacy, And Centre for Healthy Living, University of Concepción, 4070386 Concepción, Chile.ORCID https://orcid.org/0000-0003-3183-7623
Dinara SatmbekovaHigh School of Medicine, Al-Farabi Kazakh National University, Almaty, Kazakhstan.ORCID https://orcid.org/0000-0003-1087-3932
Balakyz YeskaliyevaFaculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty, Kazakhstan.ORCID https://orcid.org/0000-0002-1745-2738
Javad Sharifi-RadFacultad de Medicina, Universidad del Azuay, Cuenca, Ecuador.ORCID https://orcid.org/0000-0002-7301-8151
Naeem RasoolDepartment Pharmacology and Toxicology, University of Veterinary and Animals Science, Lahore, Pakistan.
Monica ButnariuBanat's University of Agricultural Sciences and Veterinary Medicine "King Michael I of Romania" from Timisoara, Timisoara, Romania.ORCID https://orcid.org/0000-0002-2032-5000
Iulia Cristina BagiuVictor Babes University of Medicine and Pharmacy of Timisoara Department of Microbiology, Timisoara, Romania.ORCID https://orcid.org/0000-0003-3099-8249
Radu Vasile BagiuVictor Babes University of Medicine and Pharmacy of Timisoara Department of Microbiology, Timisoara, Romania.ORCID https://orcid.org/0000-0002-1528-5630
Daniela CalinaDepartment of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID https://orcid.org/0000-0002-1523-9116
William C ChoDepartment of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong.ORCID https://orcid.org/0000-0003-4174-4586
Lovely Professional University · INAl-Farabi Kazakh National University · KZRede de Química e Tecnologia · PTVictor Babeș University of Medicine and Pharmacy Timișoara · ROArturo Prat University · CLHealth Research Institute of the Balearic Islands · ESIMU University · MYInstituto de Salud Carlos III · ESPolytechnic Institute of Bragança · PTQueen Elizabeth Hospital · CNUniversidad de La Frontera · CLUniversidad del Azuay · ECUniversity of Concepción · CLUniversity of Medicine and Pharmacy of Craiova · ROUniversity of Technology Sydney · AUUniversity of Veterinary and Animal Sciences · PKUnivesity of Life Science "King Mihai I" from Timisoara · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bergapten (BP) or 5-methoxypsoralen (5-MOP) is a furocoumarin compound mainly found in bergamot essential oil but also in other citrus essential oils and grapefruit juice. This compound presents antibacterial, anti-inflammatory, hypolipemic, and anticancer effects and is successfully used as a photosensitizing agent. The present review focuses on the research evidence related to the therapeutic properties of bergapten collected in recent years. Many preclinical and

Indexed as

MethoxsalenOils, Volatile5-MethoxypsoralenHumansPhotosensitizing AgentsPlant ExtractsUltraviolet Rays5-MethoxypsoralenMethoxsalenOils, VolatilePhotosensitizing AgentsPlant Extracts

Identifiers

PMID35509838
PMCPMC9060977
OpenAlexW4224862307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.